share_log

Aurora Cannabis | 6-K: Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

Aurora Cannabis | 6-K: Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

極光大麻 | 6-K:極光大麻首席執行官Miguel Martin兼任董事會執行主席
美股SEC公告 ·  2024/09/20 19:22

牛牛AI助理已提取核心訊息

Aurora Cannabis Inc. announced CEO Miguel Martin's appointment as Executive Chairman, effective immediately. Martin, who has served as CEO since September 2020, will continue in this role while taking on additional Board leadership responsibilities. Outgoing Chairman Ron Funk transitions to Lead Independent Director.The Board believes combining the CEO and Chairman roles will promote stronger leadership and efficient decision-making as Aurora pursues global growth. Martin has driven significant organizational change, including financial recovery and business transformation. The company also announced changes to its Board committee compositions, with Michael Singer joining the Audit and HR Compensation committees, and Rajesh Uttamchandani appointed to the HR Compensation and Nominating & Corporate Governance committees.Aurora, headquartered in Edmonton, Alberta, is a global medical cannabis company serving markets across Canada, Europe, Australia, and South America. The company's portfolio includes adult-use brands like Drift and San Rafael '71, as well as medical cannabis brands such as MedReleaf and CanniMed.
Aurora Cannabis Inc. announced CEO Miguel Martin's appointment as Executive Chairman, effective immediately. Martin, who has served as CEO since September 2020, will continue in this role while taking on additional Board leadership responsibilities. Outgoing Chairman Ron Funk transitions to Lead Independent Director.The Board believes combining the CEO and Chairman roles will promote stronger leadership and efficient decision-making as Aurora pursues global growth. Martin has driven significant organizational change, including financial recovery and business transformation. The company also announced changes to its Board committee compositions, with Michael Singer joining the Audit and HR Compensation committees, and Rajesh Uttamchandani appointed to the HR Compensation and Nominating & Corporate Governance committees.Aurora, headquartered in Edmonton, Alberta, is a global medical cannabis company serving markets across Canada, Europe, Australia, and South America. The company's portfolio includes adult-use brands like Drift and San Rafael '71, as well as medical cannabis brands such as MedReleaf and CanniMed.
Aurora Cannabis Inc. 宣佈 CEO 米格爾·馬丁(Miguel Martin)立即被任命爲執行董事長。自 2020 年 9 月以來擔任 CEO 的馬丁將繼續履行這一職務,同時承擔更多董事會領導責任。卸任的董事長羅恩·芳克(Ron Funk)將轉任首席獨立董事。董事會認爲,結合 CEO 和董事長的角色將促進更強的領導力和有效的決策,同時推動 Aurora 實現全球增長。馬丁推動了重大的組織變革,包括財務恢復和業務轉型。公司還宣佈了董事會委員會組成的變化,邁克爾·辛格(Michael Singer)加入審計和人力資源薪酬委員會,拉傑什·烏塔姆昌達尼(Rajesh Uttamch...展開全部
Aurora Cannabis Inc. 宣佈 CEO 米格爾·馬丁(Miguel Martin)立即被任命爲執行董事長。自 2020 年 9 月以來擔任 CEO 的馬丁將繼續履行這一職務,同時承擔更多董事會領導責任。卸任的董事長羅恩·芳克(Ron Funk)將轉任首席獨立董事。董事會認爲,結合 CEO 和董事長的角色將促進更強的領導力和有效的決策,同時推動 Aurora 實現全球增長。馬丁推動了重大的組織變革,包括財務恢復和業務轉型。公司還宣佈了董事會委員會組成的變化,邁克爾·辛格(Michael Singer)加入審計和人力資源薪酬委員會,拉傑什·烏塔姆昌達尼(Rajesh Uttamchandani)被任命爲人力資源薪酬委員會和提名及公司治理委員會成員。Aurora 總部位於艾德蒙頓,阿爾伯塔省,是一家全球醫療 cannabis 公司,服務於加拿大、歐洲、澳洲和南美的市場。公司的產品組合包括成人使用品牌如 Drift 和 San Rafael '71,以及醫療 cannabis 品牌如 MedReleaf 和 CanniMed。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。